- |||||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly, Jentadueto (linagliptin/metformin) / Eli Lilly, Boehringer Ingelheim
New P4 trial, Monotherapy, Head-to-Head: Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes (clinicaltrials.gov) - Jan 18, 2012 P4, N=316, Completed,
- |||||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion: Comprehensive Add on Study in Japan (clinicaltrials.gov) - Jan 16, 2012 P3, N=574, Completed, N=18 --> 58 Active, not recruiting --> Completed
|